13th March 2015
« All Articles
In the final part of his product review of Springer's new AdisInsight drug information platform, Ashish Shukla looks at customer support and gives an overview of its strengths as a single point of access platform. He analyses the overall value that the product offers to those seeking a one-stop solution on the entire drug lifecycle, from profiles of drugs in development, insights into the trials being performed to advance these drugs through regulatory pathways, to safety reports associated with a drug, and any deals undertaken by the organisations involved.
Note: Full review (PDF) at https://web.jinfo.com/go/sub/report/2468
Access to Jinfo articles and reports is a benefit of a Jinfo Subscription.
Please sign in here so that we can check your access to this item:
If this item has been shared with you by a colleague, please request a MyJinfo account.
Gain access to this article with a Jinfo Subscription. It will help your organisation:
Benefits and Pricing
Submit the Subscription Question form to find out if someone in your organisation already has a subscription or to discuss your questions or requirements.Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
Claire LaybatsHead of Commercial Developmentclaire.firstname.lastname@example.org
About this article
Related Subscription Articles:
Related Subscription Reports:
Back to top ^
Login to MyJinfo if you already have a Jinfo Subscription
"Intelligence systems - intelligence 2020"
In the 10 years plus we've been researching developments in news and current awareness, we've predicted and then seen a significant shift from current awareness to intelligence systems. (October - December 2019).
Research Focus »
... more items ...
Visit the Blog »
... more articles ...
... more reports ...
All Content »
© Jinfo Limited 1997-2019 · Cookies, Privacy, Legal